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Background: Crohn’s disease (CD) is routinely evaluated using clinical symptoms, laboratory variables, and the CD
activity index (CDAI). However, clinical parameters are often nonspecific and do not precisely reflect the actual
activity of CD small-intestinal lesions. The purposes of this prospective study were to compare color Doppler
ultrasound (US) findings with histological findings from surgically resected specimens and confirm the hypothesis
that color Doppler US can distinguish tissue inflammation and fibrosis.
Methods: Among 1764 consecutive patients who underwent color Doppler US examinations, 10 patients with CD
(12 small-intestinal CD lesions) who underwent US examinations before elective small-intestine resection were
evaluated in the present study. Areas of thickened intestinal walls were evaluated in terms of blood flow using color
Doppler US imaging. The blood flow was semiquantitatively classified as “hyper-flow” and “hypo-flow” according
to the Limberg score. Resected lesions were macroscopically and histopathologically processed. Inflammatory cell
infiltration, fibrosis and vascularity were evaluated by myeloperoxidase (granulocytes), CD163 (macrophages), CD79a
(B cells), CD3 (T cells), Masson’s trichrome (fibrosis), and factor VIII staining (vascular walls). All histopathological
images were entered into virtual slide equipment and quantified using a quantitative microscopy integrated system
(TissueMorph™).
Results: There were no significant differences in disease features or laboratory findings between “hypo-flow” lesions
(n = 4) and “hyper-flow” lesions (n = 8). Histopathologically, “hyper-flow” lesions showed significantly greater bowel
wall vascularity (factor VIII) (p = 0.047) and inflammatory cell infiltration, including CD163 macrophages (p = 0.008),
CD3 T cells, and CD79a B cells (p = 0.043), than did “hypo-flow” lesions. There was no apparent association between
the blood flow and CDAI.
Conclusions: In this study, active CD lesions were macroscopically visible in surgical specimens of patients with
increased blood flow on preoperative color Doppler US imaging. Additionally, these CD lesions exhibited
significantly greater vascularity and numbers of inflammatory leukocytes microscopically. Color Doppler US may
predict tissue inflammation and fibrosis in small-intenstinal CD lesions.
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Crohn’s disease (CD) is a chronic inflammatory disease of
the intestine that follows a pattern of relapse and remis-
sion characterized by segmental and transmural inflam-
mation that can lead to luminal stricture. CD activity is
generally assessed using a combination of clinical symp-
toms, blood tests, the CD activity index (CDAI), and im-
aging techniques [1,2]. However, clinical symptoms and
laboratory test results are often nonspecific, and judging
whether these signify the presence of active lesions or ob-
struction due to fibrotic strictures is generally difficult. Es-
pecially, a lesion in the small intestine lying deep in the
abdomen rarely contributes to clinical symptoms or is de-
tected in blood tests, even in patients with relapsing enter-
itis, and is difficult to approach by endoscopy. Numerous
studies have demonstrated the ability of a variety of im-
aging modalities to predict CD disease activity [3-9], but
to date, no study has been able to assess the degree of in-
flammation accurately. Because a single absolute reference
method to assess disease activity is lacking, multiple pa-
rameters and imaging modalities are often used.
The European guidelines for CD diagnosis recommend
transabdominal ultrasound (US), magnetic resonance im-
aging (MRI), and computed tomography (CT) enterogra-
phy/enteroclysis as minimally invasive alternatives to
endoscopy and contrast imaging for examination of the
small intestine [10-12]. Color Doppler US is a noninvasive
method for evaluating intestinal wall blood flow; therefore,
this method should be appropriate for assessment of CD
activity [13,14]. When compared with conventional CT or
MRI, transabdominal US has the advantage of high spatial
resolution, which allows external examination of the five-
layered mural structure and transmural hypervascularity
in the inflamed intestinal wall, and may help to detect the
inflammatory activity of focal CD lesions [15-18].
We investigated whether or not increased blood flow to
the intestinal wall observed on US implies histopatho-
logical inflammation of CD lesions. Data on histological
correlations of color Doppler US are still lacking, and few
studies have performed histological evaluations of a small
number of cases [19-21]. Accordingly, we aimed to com-
pare intestinal wall blood flow by color Doppler US with
quantitatively measured histopathological findings of in-




Patients who underwent color Doppler US examinations
at the Yokohama City University Medical Center from
January 2008 to March 2012 were identified. Patients
with CD who underwent preoperative transabdominal
US prior to surgical resection of small-intestinal lesions
were eligible for this study. To ensure that the lesionobserved with color Doppler US was the same as that sur-
gically resected, patients with a single lesion (or if multiple
lesions were present, those close to the ileocecal valve)
were included. Patients with internal or external fistulae,
abscesses, and severe obstruction were excluded to elimin-
ate the possible histological influences of secondary infec-
tion such as intestinal obstruction or abscess formation.
Consequently, macroscopically representative CD cases
were included, such as those with longitudinal ulcers, a
cobblestone appearance, and fibrotic stenosis.
Prior to surgery, a detailed clinical history was collected,
including age, sex, CD duration, previous segmental re-
section, disease location, disease behavior, preoperative
therapy, site and duration of disease, number of clinical
recurrences, and type of previous medical therapy. All
patients were evaluated for clinical and biochemical ac-
tivity in terms of CDAI, C-reactive protein, and erythro-
cyte sedimentation rate. Patients were excluded if the
clinical data were incomplete.
Transabdominal US examinations
The examinations were performed by three highly experi-
enced technicians (H.Y., N.S., and A.H.) together with a
gastroenterologist (T.S.). The US examinations were
performed without any special preparation; no prior fast,
parenteral contrast reagents, or administration of oral
contrast media to achieve adequate distension. The US
equipment used was Aplio XG and XV (Toshiba Medical
Systems Corp., Tochigi, Japan). A general scan was per-
formed using a 6-MHz convex probe, and a more local-
ized and detailed scan of the affected area was conducted
using a 7.5-MHz linear probe. In the examination, the ter-
minal ileum was identified using the ileocecal valve, after
which the ileum was followed rostrally as continuously as
possible for evaluation. When the examiners lost track of
the intestine continuity, they identified a nearby intestine
from which they resumed the examination, and the entire
abdomen was searched for any detectable part of the small
intestine using the graded compression technique [22].
Areas with thicker walls than the surrounding intestine
were considered to be pathologically affected. All thick-
ened areas of the intestine were evaluated in terms of
blood flow using color Doppler US imaging. The range of
blood flow velocities for the area of interest was adjusted
to 4 cm/sec, and the color gain was reduced from the
maximum value and evaluated at the maximum gain that
eliminated noise. The blood flow was then evaluated using
the Limberg score (Figure 1) [19,23] and macroscopically
and semiquantitatively graded from Grade 0 to 4. Grade 0
was defined as a normal intestinal wall without a color
Doppler signal, without bowel wall thickness, and with a
preserved five-layer wall structure. Grade 1 was defined as
hypoechoic intestinal wall thickness with partially obliter-
ated wall layers but without increased vascularity (no color
Figure 1 Examples of semiquantitative assessment of bowel wall vascularity using Doppler US according to Limberg score. (A) Grade
0 = no bowel wall thickening, no vascularization; (B) Grade 1 = bowel wall thickening without vascularization; (C) Grade 2 (hypo-flow) = bowel
wall thickening with short stretches of vascularity as spots; (D) Grade 3 (hyper-flow) = bowel wall thickening with longer stretches of vascularity;
(E) Grade 4 (hyper-flow) = bowel wall thickening with longer stretches of vascularity reaching the mesentery.
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thickness with short stretches of vascularity (spot). Grade
3 was defined as longer stretches of vascularity, and Grade
4 as longer stretches of vascularity extending into the sur-
rounding mesentery.
In this study, we classified Grade 1 cases as “hypo-
flow” and Grade 3 and 4 cases as “hyper-flow.” Grade 0
was excluded because it was not a CD lesion and was
considered normal. Grade 2 was excluded because it was
intermediate and not a representative image and was
thus considered unsuitable for this analysis.
As described above, all cases that did not match the
preoperative US images and postoperative surgical speci-
mens were excluded from the study. Other excluded
cases were patients with deep lesions that did not ac-
commodate proper flow evaluation and patients with gas
retention due to obstruction, which made bowel evalu-
ation difficult.
Surgery
The surgical treatments for the CD lesions were per-
formed by an experienced surgeon specialized in inflam-
matory bowel disease (IBD). The resected area with the
lesion was opened longitudinally from the side opposite
to the mesenteric attachment and then fixed in buffered
formalin. The pathology slide was prepared with trans-
verse slices made at the site of pathological lesions ob-
served on the US examination.
Histopathological analyses
Resected small-intestinal segments were retrieved and
evaluated. When the resected segment for pathological
examination was prepared, the lesion location had to
match exactly with color Doppler US findings. Thus, weselected the single lesion, or if there were several lesions,
the existing terminal ileum. If the co-identity of the le-
sion in the surgical and US findings was questionable,
the case was excluded. The specimen was transversely
divided through the approximate lesion center and sub-
jected to histological examination.
The overall image of the selected sample was evaluated
after hematoxylin and eosin (H&E) staining. All samples
were reviewed by an independent expert gastrointestinal
pathologist (T.M.) and excluded if tissue specimens were
considered unsuitable for study. Evaluation of inflamma-
tory cell infiltration was performed by myeloperoxidase
(MPO) staining for granulocytes (Dako, Glostrup, Denmark),
CD163 staining (Leica MICROSYSTEMS, Wetzlar, Germany)
for macrophages, CD79a staining (Roch Diagnostics
GmbH, Mannheim, Germany) for B cells, and CD3 stain-
ing (Roch Diagnostics GmbH, Mannheim, Germany) for
T cells. Masson trichrome staining was used to evaluate fi-
brosis, and factor VIII staining (Dako, Glostrup, Denmark)
was used to identify vascular walls.
Digital images were created from all slides using a whole
slide scanner (OliVIA VS120: Olympus Corp., Tokyo,
Japan). The resulting images were digitized and quantified
using an automated quantitative microscopy integrated sys-
tem (TissueMorph™: VisioPharm, Hoersholm, Denmark).
TissueMorph™ is an analysis software module based on dig-
itized glass slides; it enables cross-sectional quantitative
analysis of bowel-wall tissue properties, excluding the mes-
enteric fat (Figure 2A). The cell membranes (Figure 2B)
and vascular endothelium (Figure 2C) were stained using
an immunologic staining method, and fibrotic areas
stained using Masson trichrome (Figure 2D) were eval-
uated and the corresponding area was quantitated. The
sum of this calculation was divided by the area used for
Figure 2 Histopathological images quantified using an automated quantitative microscopy integrated system (TissueMorph™ by
VisioPharm, Hoersholm, Denmark). (A) Immunohistochemical staining area for the entire cross-sectional analysis was recognized and delin-
eated by TissueMorph™. (B) Determination of positive staining for hematopoietic cells. Immunological staining of cell-membrane markers (left
panel) and analysis results (right panel). (C) Evaluation of vasculature. Immunological staining of the vascular walls using factor VIII (left panel) and
analysis results (right panel). (D) Determination of fibrosis. The faint blue color of positive Masson trichrome staining (left panel) was enhanced
(right panel) and identified for measurement.
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were multiplied by 10,000 for conversion into more
practical figures.
Specimens from three patients in whom a right hemico-
lectomy was performed during the same period due to colon
cancer were used as controls versus surgical specimens.
Ethical considerations
Before contacting the study subjects, our protocol was
reviewed and approved by the Screening Committee of
the Yokohama City University Medical Center. Likewise,
informed consent was obtained from all 10 patients who
were eligible and agreed to participate in this study.
Additionally, the Principle of Good Clinical Practice and
the Declaration of Helsinki were adhered to at all times.
Statistics
The IBM SPSS Statistics software, version 19 (IBM
Japan, Ltd., Tokyo, Japan) was used for statistical ana-
lysis. For comparison of continuous variables from two
data sets, the t-test was applied. Due to the small sample
size, Fisher’s exact test was used to compare data sets,
and a value of p < 0.05 was considered to indicate statis-
tical significance.Results and discussion
Baseline preoperative transabdominal color Doppler
imaging
A total of 1,764 patients underwent color Doppler US
examinations from January 2008 to March 2012; of
these, 790 patients had CD, and 743 patients who did
not undergo US before the operation and/or whose Lim-
berg score of Doppler US was 0 or 2 were excluded.
Forty-seven patients underwent surgery and had a Grade
1, 3, or 4 Limberg score. Seven patients without small
bowel lesions (colon lesions only) were excluded, and 30
patients with abscesses, fistulae, ileus, and/or difficulty
in identifying the position between US findings and sur-
gical specimens were also excluded (Figure 3). The mean
interval between surgery and US examinations was 6 days
(range, 1–16 days). Thirty patients were excluded based
on our criteria. The clinical and biochemical characteris-
tics of 12 lesions in 10 patients fulfilled the inclusion cri-
teria and were considered for analysis (Table 1). The
most common indication for surgery was recurrent ob-
struction associated with lesions in the small intestine.
Based on preoperative color Doppler imaging, the
cases were classified into “hypo-flow” (n = 4) and “hyper-
flow” (n = 8) groups. There was no significant difference
Figure 3 Inclusion and exclusion criteria for this study. A total of 1,764 patients underwent color Doppler US examinations from January
2008 to March 2012; of these, 790 patients had CD. In total, 743 patients who did not undergo US before the operation and/or whose Limberg
score of Doppler US was 0 or 2 were excluded. Forty-seven patients underwent surgery and had Grade 1, 3, or 4 Limberg score. Seven patients
without small bowel lesions (colon lesions only) were excluded, and 30 patients with abscesses, fistulae, ileus, and/or difficulty in identifying the
position between US findings and surgical specimens were also excluded.
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tory findings; e.g., disease type and preoperative treat-
ment. Additionally, there was no significant difference in
the CDAI of the two groups (Table 1).
Comparison of preoperative US flow and microscopic
quantitative evaluation of inflammatory infiltration,
vascularity, and fibrosis
Next, we compared the preoperative US flow and histo-
logical findings of the resected tissues. H&E stains showed
that inflammatory cell infiltration was more severe in the
“hyper-flow” group than the “hypo-flow” group (Figure 4).
To evaluate inflammation quantitatively, we used recently
developed quantitative digital software combined with a
whole slide scanner and an automated quantitative mi-
croscopy integrated system for immunohistochemical ana-
lysis. We found that the numbers of CD163-positive
macrophages (p = 0.044) and lymphocytes (CD3-positive
T cells and CD79a-positive B cells) (p = 0.043) were higher
in the “hyper-flow” group than in the “hypo-flow” group
(Figure 5B). The numbers of CD163-positive macrophages
and lymphocytes in both the “hyper-flow” and “hypo-flow”
groups was significantly higher than in the control speci-
mens. In contrast, the numbers of MPO-positive granulo-
cytes were almost identical among the groups, including
the controls (Figure 5B).
We also performed a vascularity evaluation by immuno-
histochemical staining using an anti-factor VIII antibody(Figure 4). Vascular length was significantly greater in the
“hyper-flow” group than in the control and “hypo-flow”
groups (“hyper-flow” vs. control, p = 0.038; “hyper-flow”
vs. “hypo-flow,” p = 0.047) (Figure 5A). Fibrosis was evalu-
ated by quantitative analysis of Masson trichrome staining.
The level of positive Masson trichrome staining in both
the “hyper-flow” and “hypo-flow” groups was significantly
higher than that in the control specimens (“hyper-flow”
vs. control, p = 0.008; “hypo-flow” vs. control, p = 0.011),
although there was no significant difference between the
“hyper-flow” and “hypo-flow” groups (Figure 5C).
In this study, we used a novel quantitative digital soft-
ware package combined with a whole slide scanner and an
automated quantitative microscopy integrated system to
evaluate the vascularity and inflammation of thickened
small intestinal areas that corresponded to the areas
scanned by color Doppler US. In the surgical specimens
that showed increased blood flow on the color Doppler
US, significant histopathological increases in vascularity
and inflammatory cell infiltration were identified. There-
fore, color Doppler US is capable of characterizing the in-
flammatory activity of CD small-intestinal lesions.
Doppler US has become widely used to assess the micro-
vasculature of various organs, and recent findings indicate
that it can assess the hemodynamics and inflammatory ac-
tivity of certain lesions [24-26]. In rheumatoid arthritis, as
demonstrated and described in the guidelines [27], there
was a strong correlation between inflammation in the
Table 1 Baseline demographic variables, disease features, and laboratory findings in patients with Crohn’s disease
(CD) selected for color Doppler ultrasound evaluations of CD lesions in the small intestine
Demography “Hypo-flow” “Hyper-flow” p value
(n = 4) (n = 8)
Age in years 40.0 ± 8.2 26.8 ± 13.8 0.1111)
Male (%) 2 (50.0) 3 (37.5) 1.0002)
CD duration in years 13.8 ± 7.8 3.9 ± 4.2 0.0811)
Previous segmental resection, % 0 0
Disease location, n (%)* 0.4912)
L1 (distal 1/3 ileum ± limited cecal) 0 (0.0) 3 (37.5)
L3 (ileocolonic) 4 (100.0) 5 (62.5)
L4b (upper, distal to ligament of Treitz and proximal to distal 1/3 ileum) 0 (0.0) 0 (0.0)
Disease behavior, n (%)*
B1 (nonstricturing, nonpenetrating) 0 (0.0) 0 (0.0)
B2 (stricturing) 4 (100.0) 8 (100.0)
B3 (penetrating) 0 (0.0) 0 (0.0)
B4 (structuring and penetrating) 0 (0.0) 0 (0.0)
Primary indication for surgery, n (%) 1.0002)
Recurrence of obstruction symptoms 4 (100.0) 7 (87.5)
Intractable disease 0 (0.0) 1 (12.5)
CDAI 196.2 ± 73.8 198.2 ± 63.9 0.9631)
C reactive protein (mg/dl) 1.30 ± 2.01 0.47 ± 0.34 0.4661)
Erythorocyte sedimentation rate (mm/h) 32.0 ± 30.0 16.9 ± 14.3 0.2511)
Preoperative therapy, n (%)
5ASA 4 (100.0) 5 (62.5) 0.4912)
Elemental diet (>900 kcal) 4 (100.0) 7 (87.5) 1.0002)
TPN 2 (50.0) 3 (37.5) 1.0002)
CS (prednisolone) 0 (0.0) 4 (50.0) 0.2082)
AZA/6MP 0 (0.0) 4 (50.0) 0.2082)
Anti-TNF-α biologics 1 (25.0) 0 (0.0) 0.3332)
Antibiotics 2 (50.0) 3 (37.5) 1.0002)
1)Student’s t-test; 2)Fisher’s exact test; *Paris classification of CD; CDAI, Crohn’s disease activity index (≥150 indicates active disease); 5ASA, 5-aminosalycilic acid;
6MP, 6-mercaptopurine; AZA, azathioprine; TPN, total parenteral nutrition.
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such as fibroblast growth factor, vascular endothelial
growth factor, TNF-α, and interleukin-1 promote vascular
proliferation in the affected synovial membrane [28-31].
Regarding CD, several reports state that increased blood
flow revealed by US may reflect CD disease activity
[8,19,32-34]. While few previous reports showed that Dop-
pler US findings correlate with inflammation based on
endoscopic biopsy specimens and/or surgical specimens
[19-21,32], our study is unique because we used surgical
pathology as the gold standard for color Doppler US. Add-
itionally, we investigated the histological inflammation and
vascularity of the resected specimen’s intestinal wall and
the correlation with the color Doppler US findings using a
recently created digital quantitative technique that enablesthe evaluation of the inflammation, vascularity, and fibrosis
of the entire cross-section of the intestinal wall. To our
knowledge, this is the first study to investigate the inflam-
matory cell infiltration and vascularity in all layers of the
small-intestinal wall.
Vascular lesions and microvascular changes, such as
granulomatous vasculitis, neovascularization, and dilata-
tion of arteries and veins, are well known to be features of
the pathogenesis of CD. According to recent reports
[35,36], there is new understanding regarding the induc-
tion of vascular proliferation during chronic CD inflam-
mation, although there is no general consensus regarding
its mechanism. Clinically, we often experience serious
bleeding incidents from active CD lesions showing
“hyper-flow” according to color Doppler US; such lesions
Figure 4 Representative examples of pathological findings of the (A) “hypo-flow” and (B) “hyper-flow” surgical specimens. H&E staining
revealed more active inflammation in “hyper-flow” (B) than in “hypo-flow” (A) cases. Vascular walls stained immunohistochemically using an
anti-factor VIII antibody and macrophages stained with an anti-CD163 antibody were more prominent in “hyper-flow” (B) compared with
“hypo-flow” (A) cases.
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Figure 5 Histopathological analysis of vascularity, inflammatory cell infiltration, and fibrosis. Tissue sections of “hyper-flow”, “hypo-flow”,
and controls were stained with anti-factor VIII antibody, anti-CD163, CD3, CD79a MPO, or Masson’s trichrome. Positive-staining cells or areas
were calculated using TissueMorph™. White, gray, and black bars represent control, “hypo-flow”, and “hyper-flow”, respectively. *p < 0.05. (A) The
vascular walls were stained using an anti-factor VIII antibody, and the numbers of factor VIII-positive cells were calculated. (B) Inflammatory cell
infiltrations were stained using anti-CD163, CD3, CD79a, and MPO antibody, and the numbers of positive-staining cells were calculated. (C) Fibrotic
areas stained using Masson’s trichrome were evaluated, and the corresponding area was quantitated.
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anti-TNF-α antibodies. Therefore, color Doppler US may
help to determine when anti-TNF-α antibody should be
administered for active small-intestinal CD lesions.
Previous reports often described a correlation be-
tween the US images of CD lesions and CDAI [8,33,37].
However, in this study there was no significant difference
between the CDAI of “hypo-flow” and “hyper-flow” cases
(Table 1). Additionally, there was no correlation be-
tween CDAI and histological vascularity (factor VIII
stain) as analyzed by TissueMorph™ (data not shown).
A poor correlation exists between the disease activity of
affected small-intestinal lesions and the clinical level of
severity as represented by inflammatory markers or the
CDAI [38].
Our study has several limitations. It was limited by the
small sample size, which included only patients who
underwent surgery at a tertiary referral center. To defini-
tively eliminate the possible histological influence of an-
other pathologic process of CD itself, only representative
CD lesions were included based on the prespecified in-
clusion criteria. Because of recent improvements in
medical therapy and endoscopic dilatation, most surgical
cases during our study were for more complicated con-
ditions, such as internal fistulae or abscess formation,
and therefore, fewer cases were available for inclusion.
Another reason for the small sample size was the limita-
tion to patients with a Limberg score of 1, 3, or 4 to
allow better evaluation of blood flow. Therefore, patients
with a Limberg score of 2, which is the most common
score, were excluded. In our another study, when we
compared the Limberg score of color Doppler US withthe endoscopic activity score (simple endoscopic score
for CD [SES-CD]), a substantial correlation was identi-
fied (ρ = 0.709, p < 0.001). A Grade 2 Limberg score was
an intermediate grade between “hypo-flow” (Grade 1)
and “hyper-flow” (Grade 3 and 4) [39]. Additionally,
there was concern regarding the accuracy of transab-
dominal US; this method has the disadvantages of being
dependent on factors such as the experience level of the
examining physician [40] and the fact that it is difficult
to perform on overweight patients.
Conclusions
Our investigation outcomes clearly reflected histological
CD activity; significant differences were noted in both
blood flow and inflammatory cell infiltration between
the “hyper-flow” and “hypo-flow” groups, and between
the aforementioned and the control specimens. In con-
clusion, our data suggest that color Doppler US can pre-
dict tissue inflammation in CD small-intestinal lesions
and is a promising modality for investigation and thera-
peutic management of CD small-intestinal lesions.
Availability of supporting data
The data sets supporting the results of this article are in-
cluded within the article and its additional files.
Competing interests
All authors declare that they have no competing interests.
Authors’ contribution
All authors have made significant contributions to this work as specified
below. TS, RK, EM, SM, KT and SM: Conception, study design, and preparation
of the manuscript draft; RK, HK, HK: Patient management and data
generation, collection, assembly, analysis, and interpretation; HK and F:
Sasaki et al. BMC Research Notes 2014, 7:363 Page 9 of 10
http://www.biomedcentral.com/1756-0500/7/363Performance of surgery and analysis and interpretation of data; AH, NS, HY,
and KN: Study conception and design, preparation of the manuscript draft,
and performance of transabdominal US examinations; TK, AN and MT: Study
conception and design and preparation and evaluation of pathological
samples; and SM: Study conception and design and performance of
statistical analysis. All authors read and approved the final manuscript.
Acknowledgements
We thank Kiyotsugu Kojima and Chika Nakajima for their outstanding work
in the evaluation of biopsy specimens.
Funding
This work was funded in part by the Olympus Corporation, Japan.
Author details
1Gastroenterological Center, Yokohama City University Medical Center,
Yokohama, Japan. 2Inflammatory Bowel Disease Center, Yokohama City
University Medical Center, Yokohama, Japan. 3Department of Pathology,
Yokohama City University Medical Center, Yokohama, Japan. 4Department of
Laboratory Medicine and Clinical Investigation, Yokohama City University
Medical Center, Yokohama, Japan. 5Department of Biostatistics and
Epidemiology, Graduate School of Medicine, Yokohama City University,
Yokohama, Japan. 6Department of Surgery, NTT Medical Center Tokyo, Tokyo,
Japan. 7Department of Pathology and Laboratory Medicine, Hirosaki City
Hospital, Aomori, Japan. 8Department of Gastroenterology, Yokohama City
University Graduate School of Medicine, Yokohama, Japan.
Received: 9 July 2013 Accepted: 26 May 2014
Published: 14 June 2014
References
1. Best WR, Becktel JM, Singleton JW, Kern F Jr: Development of a Crohn’s
disease activity index. National cooperative crohn’s disease study.
Gastroenterology 1976, 70:439–444.
2. Thia K, Faubion WA Jr, Loftus EV Jr, Persson T, Persson A, Sandborn WJ:
Short CDAI: development and validation of a shortened and simplified
Crohn’s disease activity index. Inflamm Bowel Dis 2011, 17:105–111.
3. Koh DM, Miao Y, Chinn RJ, Amin Z, Zeegen R, Westaby D, Healy JC: MR
imaging evaluation of the activity of Crohn’s disease. AJR Am J
Roentgenol 2001, 177:1325–1332.
4. Taylor SA, Punwani S, Rodriguez-Justo M, Bainbridge A, Greenhalgh R,
De Vita E, Forbes A, Cohen R, Windsor A, Obichere A, Hansmann A, Rajan J,
Novelli M, Halligan S: Mural Crohn disease: correlation of dynamic
contrast-enhanced MR imaging findings with angiogenesis and
inflammation at histologic examination–pilot study. Radiology 2009,
251:369–379.
5. Wold PB, Fletcher JG, Johnson CD, Sandborn WJ: Assessment of small
bowel Crohn disease: noninvasive peroral CT enterography compared
with other imaging methods and endoscopy–feasibility study. Radiology
2003, 229:275–281.
6. Chiorean MV, Sandrasegaran K, Saxena R, Maglinte DD, Nakeeb A, Johnson
CS: Correlation of CT enteroclysis with surgical pathology in Crohn’s
disease. Am J Gastroenterol 2007, 102:2541–2550.
7. Rapaccini GL, Pompili M, Orefice R, Covino M, Riccardi L, Cedrone A,
Gasbarrini G: Contrast-enhanced power doppler of the intestinal wall in
the evaluation of patients with Crohn disease. Scand J Gastroenterol 2004,
39:188–194.
8. Migaleddu V, Scanu AM, Quaia E, Rocca PC, Dore MP, Scanu D, Azzali L,
Virgilio G: Contrast-enhanced ultrasonographic evaluation of
inflammatory activity in Crohn’s disease. Gastroenterology 2009, 137:43–52.
9. De Franco A, Di Veronica A, Armuzzi A, Roberto I, Marzo M, De Pascalis B,
De Vitis I, Papa A, Bock E, Danza FM, Bonomo L, Guidi L: Ileal Crohn
disease: mural microvascularity quantified with contrast-enhanced
US correlates with disease activity. Radiology 2012, 262:680–688.
10. Van Assche G, Dignass A, Panes J, Beaugerie L, Karagiannis J, Allez M,
Ochsenkühn T, Orchard T, Rogler G, Louis E, Kupcinskas L, Mantzaris G,
Travis S, Stange E, European Crohn's and Colitis Organisation (ECCO):
The second European evidence-based Consensus on the diagnosis and
management of Crohn’s disease: definitions and diagnosis. J Crohns
Colitis 2010, 4:7–27.11. Dignass A, Van Assche G, Lindsay JO, Lémann M, Söderholm J, Colombel JF,
Danese S, D'Hoore A, Gassull M, Gomollón F, Hommes DW, Michetti P,
O'Morain C, Oresland T, Windsor A, Stange EF, Travis SP, European Crohn's
and Colitis Organisation (ECCO): The second European evidence-based
Consensus on the diagnosis and management of Crohn’s disease:
current management. J Crohns Colitis 2010, 4:28–62.
12. Van Assche G, Dignass A, Reinisch W, van der Woude CJ, Sturm A, De Vos
M, Guslandi M, Oldenburg B, Dotan I, Marteau P, Ardizzone A, Baumgart DC,
D'Haens G, Gionchetti P, Portela F, Vucelic B, Söderholm J, Escher J, Koletzko
S, Kolho KL, Lukas M, Mottet C, Tilg H, Vermeire S, Carbonnel F, Cole A,
Novacek G, Reinshagen M, Tsianos E, Herrlinger K, et al: The second
European evidence-based Consensus on the diagnosis and management
of Crohn’s disease: special situations. J Crohns Colitis 2010, 4:63–101.
13. Maconi G, Parente F, Bollani S, Imbesi V, Ardizzone S, Russo A, Bianchi Porro
G: Factors affecting splanchnic haemodynamics in Crohn’s disease: a
prospective controlled study using Doppler ultrasound. Gut 1998,
43:645–650.
14. Martínez MJ, Ripollés T, Paredes JM, Blanc E, Martí-Bonmatí L: Assessment
of the extension and the inflammatory activity in Crohn’s disease:
comparison of ultrasound and MRI. Abdom Imaging 2009, 34:141–148.
15. Fraquelli M, Colli A, Casazza G, Paggi S, Colucci A, Massironi S, Duca P,
Conte D: Role of US in detection of Crohn’s disease: meta-analysis.
Radiology 2005, 236:95–101.
16. Maconi G, Bollani S, Bianchi PG: Ultrasonographic detection of intestinal
complications in Crohn’s disease. Digest Dis Sci 1996, 41:1643–1648.
17. Maconi G, Radice E, Greco S, Bianchi Porro G: Bowel ultrasound in Crohn’s
disease. Best Pract Res Clin Gastroenterol 2006, 20:93–112.
18. Nylund K, Ødegaard S, Hausken T, Folvik G, Lied GA, Viola I, Hauser H, Gilja
OH: Sonography of the small intestine. World J Gastroenterol 2009,
15:1319–1330.
19. Drews BH, Barth TF, Hänle MM, Akinli AS, Mason RA, Muche R, Thiel R, Pauls
S, Klaus J, von Boyen G, Kratzer W: Comparison of sonographically
measured bowel wall vascularity, histology, and disease activity in
Crohn’s disease. Eur Radiol 2009, 19:1379–1386.
20. Kratzer W, von Tirpitz C, Mason R, Reinshagen M, Adler G, Möller P, Rieber A,
Kächele V: Contrast-enhanced power Doppler sonography of the
intestinal wall in the differentiation of hypervascularized and
hypovascularized intestinal obstructions in patients with Crohn’s disease.
J Ultrasound Med 2002, 21:149–157.
21. Ripollés T, Rausell N, Paredes JM, Grau E, Martínez MJ, Vizuete J:
Effectiveness of contrast-enhanced ultrasound for characterisation of
intestinal inflammation in Crohn's disease: a comparison with surgical
histopathology analysis. J Crohns Colitis 2013, 7:120–128.
22. Puylaert JB: Acute appendicitis: US evaluation using graded compression.
Radiology 1986, 158:355–360.
23. Limberg B: Diagnosis of chronic inflammatory bowel disease by
ultrasonography. Z Gastroenterol 1999, 37:495–508.
24. Strobel D, Goertz RS, Bernatik T: Diagnostics in inflammatory bowel
disease: ultrasound. World J Gastroenterol 2011, 17:3192–3197.
25. Chamberland D, Jiang Y, Wang X: Optical imaging: new tools for arthritis.
Integr Biol (Camb) 2010, 2:496–509.
26. Pavlica P, Barozzi L: Imaging of the acute scrotum. Eur Radiol 2001, 11:220–228.
27. Backhaus M, Burmester GR, Gerber T, Grassi W, Machold KP, Swen WA,
Wakefield RJ, Manger B, Working Group for Musculoskeletal Ultrasound in
the EULAR Standing Committee on International Clinical Studies including
Therapeutic Trials: Guidelines for musculoskeletal ultrasound in
rheumatology. Ann Rheum Dis 2001, 60:641–649.
28. Walther M, Harms H, Krenn V, Radke S, Faehndrich TP, Gohlke F: Correlation
of power Doppler sonography with vascularity of the synovial tissue of
the knee joint in patients with osteoarthritis and rheumatoid arthritis.
Arthritis Rheum 2001, 44:331–338.
29. Taylor PC: VEGF and imaging of vessels in rheumatoid arthritis. Arthritis
Res 2002, 4:99–107.
30. Vreju F, Ciurea M, Roşu A, Muşetescu A, Grecu D, Ciurea P: Power Doppler
sonography, a non-invasive method of assessment of the synovial
inflammation in patients with early rheumatoid arthritis. Rom J Morphol
Embryol 2011, 52:637–643.
31. Marrelli A, Cipriani P, Liakouli V, Carubbi F, Perricone C, Perricone R,
Giacomelli R: Angiogenesis in rheumatoid arthritis: a disease specific
process or a common response to chronic inflammation? Autoimmun Rev
2011, 10:595–598.
Sasaki et al. BMC Research Notes 2014, 7:363 Page 10 of 10
http://www.biomedcentral.com/1756-0500/7/36332. Di Sabatino A, Armellini E, Corazza GR: Doppler sonography in the
diagnosis of inflammatory bowel disease. Digest Dis 2004, 22:63–66.
33. Spalinger J, Patriquin H, Miron MC, Marx G, Herzog D, Dubois J, Dubinsky
M, Seidman EG: Doppler US in patients with Crohn’s disease: vessel
density in the diseased bowel reflects disease activity. Radiology 2000,
217:787–791.
34. Esteban JM, Maldonado L, Sanchiz V, Minguez M, Benages A: Activity of
Crohn’s disease assessed by color Doppler ultrasound analysis of the
affected loops. Eur Radiol 2001, 11:1423–1428.
35. Koutroubakis IE, Tsiolakidou G, Karmiris K, Kouroumalis EA: Role of angiogenesis
in inflammatory bowel disease. Inflamm Bowel Dis 2006, 12:515–523.
36. Hatoum OA, Heidemann J, Binion DG: The intestinal microvasculature as a
therapeutic target in inflammatory bowel disease. Ann N Y Acad Sci 2006,
1072:78–97.
37. Kumar P, Domjan J, Bhandari P, Ellis R, Higginson A: Is there an association
between intestinal perfusion and Crohn’s disease activity? a feasibility
study using contrast-enhanced ultrasound. Br J Radiol 2009, 82:112–117.
38. Hanauer SB, Sandborn W, Practice Parameters Committee of the American
College of GastroenterologyPractice Parameters Committee of the American
College of Gastroenterology: Management of Crohn’s disease in adults.
Am J Gastroenterol 2001, 96:635–643.
39. Sasaki T, Kunisaki R, Kinoshita H, Yamamoto H, Kimura H, Hanzawa A,
Shibata N, Yonezawa H, Miyajima E, Sakamaki K, Numata K, Tanaka K, Maeda
S: Use of color Doppler ultrasonography for evaluating vascularity of
small intestinal lesions in Crohn's disease: correlation with endoscopic
and surgical macroscopic findings. Scand J Gastroenterol 2014, 49:295–301.
40. Panés J, Bouzas R, Chaparro M, García-Sánchez V, Gisbert JP, De Martínez
Guereñu B, Mendoza JL, Paredes JM, Quiroga S, Ripollés T, Rimola J:
Systematic review: the use of ultrasonography, computed tomography
and magnetic resonance imaging for the diagnosis, assessment of
activity and abdominal complications of Crohn’s disease. Aliment
Pharmacol Ther 2011, 34:125–145.
doi:10.1186/1756-0500-7-363
Cite this article as: Sasaki et al.: Doppler ultrasound findings correlate
with tissue vascularity and inflammation in surgical pathology
specimens from patients with small intestinal Crohn’s disease. BMC
Research Notes 2014 7:363.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
